Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Fusion Pharmaceuticals Inc
About FUSN
Fusion Pharmaceuticals Inc. is a clinical-stage oncology company. The Company is focused on developing radiopharmaceuticals as precision medicines. It has developed its Targeted Alpha Therapies (TAT), platform to enable it to connect alpha particle emitting isotopes to various targeting molecules to selectively deliver the alpha particle payloads to tumors. The TAT platform is underpinned by its ability to radiolabel various classes of targeting molecules, its research and insights into the underlying chemistry and biology of alpha emitting radiopharmaceuticals, its differentiated capabilities in target identification, candidate generation, manufacturing and supply chain, its Fast-Clear linker technology used in conjunction with antibody-based targeting molecules, and development of imaging agents. Its clinical portfolio includes FPI-2265, FPI-1434 and FPI-2059. FPI-2265 targeting prostate specific membrane antigen for metastatic castration resistant prostate cancer in a Phase 2 trial.
Find out what a historical investment in Fusion Pharmaceuticals Inc would be worth today using our FUSN stock calculator.
Market Capitalisation
-
Price-earnings ratio
-
Dividend yield
-
Volume
-
High today
-
Low today
-
Open price
-
52-week high
-
52-week low
-
Ready to start your investing journey with Stake?
Open an accountHow do I buy FUSN shares in Australia?
Buying FUSN shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Fusion Pharmaceuticals Inc in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in FUSN
What is the ticker symbol of Fusion Pharmaceuticals Inc?
The ticker symbol for Fusion Pharmaceuticals Inc is FUSN.
How much is one share of FUSN?
One share of FUSN is valued at $21.55 as of 17 May 2026.
What is the market capitalisation of Fusion Pharmaceuticals Inc FUSN?
As of 17 May 2026 Fusion Pharmaceuticals Inc has a market cap of -.
What is the 52-week high for Fusion Pharmaceuticals Inc stock?
The Fusion Pharmaceuticals Inc 52-week high stock price is $NaN.
What is the 52-week low for Fusion Pharmaceuticals Inc stock?
The Fusion Pharmaceuticals Inc 52-week low stock price is $NaN.
Can I buy FUSN shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy FUSN shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in FUSN on Stake
- Buy FUSN from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of FUSN from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
FUSN related stocks